Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-06-27
1990-01-30
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548542, C07D20748, A61K 3140
Patent
active
048974145
ABSTRACT:
Compounds useful in the treatment of patients suffering from intellectual or nervous asthenias, memory failures, senescence or mental strain of the formula (I) ##STR1## in which R' represents hydrogen, linear, branched or cyclic alkyl containing up to 8 carbon atoms, alkenyl containing from 2 to 8 carbon atoms, acyl containing from 1 to 6 carbon atoms or aralkyl containing from 7 to 15 carbon atoms and R represents aryl containing up to 14 carbon atoms, possibly substituted, or a mono- or polycyclic heterocyclic aromatic radical possibly substituted; also process and intermediates for their preparation, therapeutic compositions containing those compounds and method of use.
REFERENCES:
patent: 3117975 (1964-01-01), Bortnick et al.
patent: 3423426 (1969-01-01), Kohn
patent: 3686169 (1972-08-01), Coran et al.
patent: 4585769 (1986-04-01), Roger
Drugs of the Future, vol. 10, No. 12, 1985, pp. 972, 974.
Barzaghi Fernando
Galliani Giulio
Toja Emilio
Zirotti Carlo
Roussel UCAF
Springer David B.
LandOfFree
Derivatives of 1-benzensulphonyl-2-oxo-5-alkylthio pyrrolidine, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 1-benzensulphonyl-2-oxo-5-alkylthio pyrrolidine, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 1-benzensulphonyl-2-oxo-5-alkylthio pyrrolidine, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923736